Astrocyte Senescence as a Component of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n = 4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n = 6; P = 0.02) and 78 to 90 years (n = 11; P<10(-6)). In addition, the frontal cortex of AD patients (n = 15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n = 25; P = 0.02) and fetal controls (n = 4; P<10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (Aβ(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In many prevalent neurodegenerative conditions including Alzheimer's Disease, brain tissue biopsies are present with increased levels of p16INK4a- positive astrocytes, MMP-1 and IL-6”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Astrocytes cultured from patients with AD express not only more of the CDKi p16 INK4A than age-matched controls, but also more MMP1 and IL-6 (57).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have highlighted senescence in multiple brain cell types in AD [3, 16, 32, 52, 80].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the context of aging and neurodegenerative disease, senescent cell accumulation has been identified in multiple cell types within the central nervous system (CNS), including neurons6,7,14,15, astrocytes16,17, microglia8,18, oligodendrocyte precursor cells19 and endothelial cells20.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, prior research conducted on postmortem brain tissue from individuals with AD has identified senescent astrocytes16, and mouse models have demonstrated that they are cleared with senolytic treatment8,17.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Staining for Senescence-associated b-galactosidase Senescence-associated beta-galactosidase (SA b-gal) staining was performed as previously described [62].”
MethodThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 11×
“One component of the SASP present in multiple cell types is IL-6.”
BackgroundInfluentialAstrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 1×
“Astrocytes regulate the contents of the synaptic cleft and synaptic transmission as part of the tripartite synapse, control CNS metabolism, and maintain blood brain barrier integrity [10,11].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The increased dosage of synthetic versus cell-derived Ab oligomers required to trigger senescence, correlates with reports on the effects of Ab on rat hippocampal long-term potentiation [53].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“demonstrated by the phenotypic improvement observed following the targeted removal of senescent cells in a progeroid mouse model [9].”
BackgroundInfluentialMechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · cited 1×
“In vitro, we found that exposure of astrocytes to Ab1–42 triggers senescence and that senescent astrocytes produce high quantities of interleukin-6 (IL-6), a cytokine known to be increased in the CNS of AD patients [18].”
Background2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“We selected the age ranges of 35–50 years and 78–90 years (Figure 3B) in order to compare a group that is least likely to have AD and a group that is most likely to have AD [31].”
MethodBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Cited by
Items 301–400 of 589
Ahmad, A., Braden, A. A., Khan, S., Xiao, J., & Khan, M. M. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01016-7 · Cited by 35
“For instance, increased senescence has been detected in cultured glia cells derived from the brains of rats and humans with AD following Aβ oligomers treatment [ 120, 121].”
Guo, X., Sun, G., Zhou, T., Xu, X., Zhu, Z., Rukachaisirikul, V., Hu, L., & Shen, X. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.80 · Cited by 26
Astrocytic C–X–C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity
Perez‐Nievas, B. G., Johnson, L., Beltran-Lobo, P., Hughes, M. M., Gammallieri, L., Tarsitano, F., Myszczynska, M. A., Vázquez-Villaseñor, I., Jiménez-Sánchez, M., Troakes, C., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02371-0 · Cited by 25
“However, the specific contribution of reactive astrocytes to AD pathogenesis remains unclear, with some suggesting that reactive astrocytes lose synaptic and neuronal support functions [30] or that astrocytes undergo cellular senescence in AD [31].”
BackgroundSenescence in aging and disorders of the central nervous system
Swenson, B. L., Meyer, C. F., Bussian, T. J., & Baker, D. J. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.01.002 · Cited by 24
Δ133p53α Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity
Ungerleider, K., Beck, J. A., Lissa, D., Joruiz, S. M., Horikawa, I., & Harris, C. C. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.004 · Cited by 27
Cellular senescence and frailty: a comprehensive insight into the causal links
Marcozzi, S., Bigossi, G., Giuliani, M. E., Giacconi, R., Piacenza, F., Cardelli, M., Brunetti, D., Segala, A., Valerio, A., Nisoli, E., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00960-w · Cited by 28
“For example, senescent astrocytes (p16-positive) have been observed to increase in the aging brain, with the highest levels in the brains of Alzheimer’s disease patients [175].”
BackgroundHIV Infection, Antiretroviral Drugs, and the Vascular Endothelium
Kanmogne, G. D. (2024) · Cells · doi:10.3390/cells13080672 · Cited by 26
“In fact, there is evidence of a link between the premature senescence of CNS cells and the development/presence of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease [148–150].”
BackgroundPaidlewar, M., Kumari, S., Dhapola, R., Sharma, P., & HariKrishnaReddy, D. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112940 · Cited by 28
Graves, S. I., Meyer, C. F., Jeganathan, K. B., & Baker, D. J. (2025) · Neuron · doi:10.1016/j.neuron.2025.04.020 · Cited by 27
Napoletani, G., Protto, V., Marcocci, M. E., Nencioni, L., Palamara, A. T., & Chiara, G. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126279 · Cited by 28
Rudnitskaya, E. A., Burnyasheva, A. O., Kozlova, T. A., Peunov, D., Kolosova, N. G., & Stefanova, N. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031134 · Cited by 26
“Insofar as astrocyte senescence is induced by Aβ and oxidative stress [58], the influence of SkQ1 supplementation on the astrocyte gene expression profile is to be expected.”
BackgroundInvolvement of lncRNA TUG1 in HIV-1 Tat-Induced Astrocyte Senescence
Pillai, P. P., Kannan, M., Sil, S., Singh, S., Thangaraj, A., Chivero, E. T., Dagur, R. S., Tripathi, A., Hu, G., Periyasamy, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054330 · Cited by 25
“The accumulation of senescent astrocytes has also been demonstrated in Alzheimer’s disease [33] and is associated with exposure of the host to environmental factors leading to the development of Parkinson’s disease [34].”
BackgroundResultMolecules of senescent glial cells differentiate Alzheimer’s disease from ageing
Dai, L., Gao, F., Wang, Q., Lv, X.-Y., Cheng, Z.-Z., Wu, Y., Chai, X., Zetterberg, H., Blennow, K., Levey, A., et al. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-330743 · Cited by 26
“that AD-characterized pathologies, including amyloid-β (Aβ) deposition and tau aggregation, exacerbate glial-cell senescence (8, 11).”
BackgroundViel, T. A., Chinta, S. J., Rane, A., Chamoli, M., Buck, H. S., & Andersen, J. K. (2020) · Aging · doi:10.18632/aging.103449 · Cited by 26
“SA-β-gal staining was performed according to the method described by Bhat and co-workers [19].”
MethodInduction, regulation and roles of neural adhesion molecule L1CAM in cellular senescence
Mrázková, B., Dzijak, R., Hornofova, T., Kyjacová, L., Baráth, P., Džubák, P., Holub, D., Hajdúch, M., Nahácka, Z., Anděra, L., et al. (2018) · Aging · doi:10.18632/aging.101404 · Cited by 29
“Indeed, there is accumulating evidence that SC contribute to pathogenesis of several aging-associated degenerative diseases including atherosclerosis [21], cartilage degeneration leading to osteoarthritis [22, 23], cardiac fibrosis [24], liver fibrosis [25], type 2 diabetes [26], and Alzheimer’s and Parkinson’s diseas…”
BackgroundConnecting vascular aging and frailty in Alzheimer’s disease
Sabbatinelli, J., Ramini, D., Giuliani, A., Recchioni, R., Spazzafumo, L., & Olivieri, F. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111444 · Cited by 25
Reflections on the role of senescence during development and aging
Triana-Martínez, F., Pedraza-Vázquez, G., Maciel-Barón, L. Á., & Königsberg, M. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.04.004 · Cited by 24
Ask, T. F., Lugo, R. G., & Sütterlin, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00726 · Cited by 24
“The factors that the SASP secrete include proteases, cytokines such as TNF-α, IL-6, and IL-8, growth factors such as insulin-like growth factor binding proteins (IGFBPs), among others (Bhat et al., 2012; Tchkonia et al., 2013).”
BackgroundDufour, B. D., Bartley, T., McBride, E., Allen, E., McLennan, Y. A., Hagerman, R. J., & Martínez‐Cerdeño, V. (2024) · Annals of Neurology · doi:10.1002/ana.26851 · Cited by 23
“Additionally, astroglial senescence (AS) occurs in healthy aging, 55 at increased levels in neurodegeneration, 56 and could plausibly contribute to FXTAS neuropathological progression.”
BackgroundHan, X., Lei, Q., Liu, H., Zhang, T., & Gou, X. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad278 · Cited by 22
Tangavelou, K., & Bhaskar, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212335 · Cited by 25
“The presence of senescence markers p16 and matrix metalloproteinase-1 (MMP-1) in astrocytes have been identified in the frontal cortex of human autopsy AD brains, and upon treatment with A β 1–42 oligomers, suggesting that astrocytes are also senescent in human AD brains [104].”
Balasubramanian, P., Branen, L., Sivasubramanian, M. K., Monteiro, R., & Subramanian, M. (2021) · Aging · doi:10.18632/aging.203111 · Cited by 24
“Bhat et al showed evidence for replicative senescence in astrocytes where the isolated primary astrocytes from postmortem AD patients underwent growth arrest in late passages when compared to early passages [40].”
ResultFunctional Assessment of Stroke-Induced Regulation of miR-20a-3p and Its Role as a Neuroprotectant
Branyan, T. E., Selvamani, A., Park, M. J., Korula, K. E., Kosel, K., Srinivasan, R., & Sohrabji, F. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00945-x · Cited by 25
The context-dependent effect of cellular senescence: From embryogenesis and wound healing to aging
Lavarti, R., Alvarez-Diaz, T., Marti, K., Kar, P., & Raju, R. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102760 · Cited by 21
Dynamic Aging: Channeled Through Microenvironment
Tan, Q., Liang, N., Zhang, X., & Li, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.702276 · Cited by 28
Gomaa, A. A., Farghaly, H. A., Abdel-Wadood, Y. A., & Gomaa, G. A. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02154-7 · Cited by 27
Metabolic Reprogramming in HIV-Associated Neurocognitive Disorders
Allen, C. N. S., Arjona, S. P., Santerre, M., de Lucia, C., Koch, W. J., & Sawaya, B. E. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.812887 · Cited by 21
Alotaibi, M. R., Alaqil, F. A., Alqahtani, F., Alanazi, M., Nadeem, A., Ahmad, S. F., Lapresa, R., Alharbi, M., Alshammari, A., Alotaibi, M., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.891593 · Cited by 25
“In addition to apoptosis, several reports have suggested a role for cellular senescence in the pathogenesis of neurodegeneration (Bhat et al., 2012; Birger et al., 2019; Nicaise et al., 2019; PerezGrovas-Saltijeral et al., 2020).”
BackgroundFessel, W. J. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517698790 · Cited by 21
Senotherapeutics for HIV and aging
Szaniawski, M. A., & Spivak, A. M. (2019) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000609 · Cited by 25
SuperAgers and centenarians, dynamics of healthy ageing with cognitive resilience
Islam, M. A., Sehar, U., Sultana, O. F., Mukherjee, U., Brownell, M., Kshirsagar, S., & Reddy, P. H. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111936 · Cited by 23
Gallo, L. H., Akanda, N., Autar, K., Patel, A., Cox, I. M., Powell, H. A., Grillo, M., Barakat, N. M., Morgan, D., Guo, X., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14044 · Cited by 22
“40,41 In the Alzheimer’s brain, glial, 66 astrocytes, 67 and neuronal populations, 68 Furthermore, this model identified various SASP secreted by aging cortical neurons, some of which have been previously detected in the brain, CSF, and plasma samples of patients diagnosed with MCI and AD (Table 1).”
Lanzillotta, C., Zuliani, I., Vasavda, C., Snyder, S. H., Paul, B. D., Perluigi, M., Domenico, F. D., & Barone, E. (2020) · Antioxidants · doi:10.3390/antiox9080671 · Cited by 23
“As previously reported, loss of p62/SQSTM1 leads to increased oxidative stress, possibly eliciting a stress-induced senescence response in astrocytes [83], which can also contribute to the progression of AD and other neurodegenerative diseases [84,85].”
BackgroundHypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease
Salminen, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104919 · Cited by 25
Defining and characterizing neuronal senescence, ‘neurescence’, as GX arrested cells
Hudson, H. R., Rießland, M., & Orr, M. E. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.09.006 · Cited by 26
From Neuron‐Centric to Glia‐Centric: How Aging Glial Networks Drive Neurodegenerative Disease
Hayashide, L. D. S., Pessoa, B., Dias, G. R., Pontes, B., Pinto, R. S., & Diniz, L. P. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70361 · Cited by 21
“Studies have shown an increase in senescent astrocytes expressing p16INK4a and matrix metalloproteinase 1 (MMP-1) in aged and Alzheimer's brains (Bhat et al. 2012).”
Cellular senescence in vivo: From cells to tissues to pathologies
Kumar, A., Bano, D., & Ehninger, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111308 · Cited by 20
New Trends in Aging Drug Discovery
Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., López-Rodríguez, M. L., & Ortega‐Gutiérrez, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082006 · Cited by 22
“Brain functions diminish with age and numerous reports have concluded that cell senescence contributes to the pathogenesis of neurodegenerative diseases [59], especially AD [60] and PD [61], but also of other pathologies such as Huntington’s disease (HD) [62], multiple sclerosis (MS) [63], and amyotrophic lateral scle…”
BackgroundHuang, Z., Xu, P., Hess, D. C., & Zhang, Q. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00457-2 · Cited by 20
Clasmatodendrosis and β‐amyloidosis in aging hippocampus
Mercatelli, R., Lana, D., Bucciantini, M., Giovannini, M. G., Cerbai, F., Quercioli, F., Zecchi‐Orlandini, S., Delfino, G., Wenk, G. L., & Nosi, D. (2015) · The FASEB Journal · doi:10.1096/fj.15-275503 · Cited by 21
Late Passage Cultivation Induces Aged Astrocyte Phenotypes in Rat Primary Cultured Cells
Bang, M., Gonzales, E. L., Shin, C. Y., & Kwon, K. J. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.175 · Cited by 19
“Aged astrocytes show flattened morphology and increase the number of senescence-associated -galactosidase-positive cells (SA--gal-positive cells) and senescence-associated secretory phenotypes (SASPs) (Enokido et al., 2008; Campuzano et al., 2009; Campisi et al., 2011; Salminen et al., 2011; Bhat et al., 2012; Yoon…”
BackgroundInfluentialSenescence in RASopathies, a possible novel contributor to a complex pathophenoype
Engler, M., Fidan, M., Nandi, S., & Cirstea, I. C. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111411 · Cited by 16
“, 2007) and astrocytes (Bhat et al., 2012; Bitto et al., 2010), however, further studies are needed to prove the extent to which senescence affects brain cells and its physiological impact.”
Trimethylamine N-oxide: role in cell senescence and age-related diseases
Zhang, L., Yu, F., & Xia, J. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-03011-w · Cited by 21
“In vitro, they found that astrocytes exposed to Aβ 1–42 become senescent, and that senescent astrocytes produce large amounts of IL-6, a cytokine known to increase in the CNS of AD patients [53].”
BackgroundAre cytoskeleton changes observed in astrocytes functionally linked to aging?
Villablanca, C., Vidal, R. L., & González-Billault, C. E. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.03.007 · Cited by 20
Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study
Papadopoulos, D., Magliozzi, R., Bandiera, S., Cimignolo, I., Barusolo, E., Probert, L., Gorgoulis, V. G., Reynolds, R., & Nicholas, R. S. (2025) · Annals of Neurology · doi:10.1002/ana.27195 · Cited by 19
Muraleedharan, A., Rotem‐Dai, N., Strominger, I., Anto, N. P., Isakov, N., Monsonego, A., & Livneh, E. (2020) · Glia · doi:10.1002/glia.23921 · Cited by 21
Morales-Rosales, S. L., Santín-Márquez, R., Posadas-Rodriguez, P., Rincon-Heredia, R., Montiel, T., Librado-Osorio, R., Luna-López, A., Rivero-Segura, N. A., Torres, C., Cano-Martínez, A., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.766306 · Cited by 17
Self-citationZhang, T., Luu, M. D. A., Dolga, A. M., Eisel, U. L. M., & Schmidt, M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1207280 · Cited by 21
“In AD patients and mouse models, elevated senescent markers, p16, p21, p53 and senescence associated β-Galactosidase (SA-β-Gal) were observed (Arendt et al., 1996; Arendt et al., 1998; McShea et al., 1997; Lüth et al., 2000; Engidawork et al., 2001; Hochstrasser et al., 2011; Esteras et al., 2012; Esteras et al., 2013…”
BackgroundLuca, S. N. D., & Vlahos, R. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16263 · Cited by 23
Tenovin-1 Induces Senescence and Decreases Wound-Healing Activity in Cultured Rat Primary Astrocytes
Bang, M., Ryu, O., Kim, D. G., Mabunga, D. F., Cho, K. S., Kim, Y., Han, S.-H., Kwon, K. J., & Shin, C. Y. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.107 · Cited by 17
“Senescence also increases IL-6 in human astrocytes (Bhat et al., 2012; Correale and Farez, 2015; Hou et al., 2017).”
BackgroundWang, Y., Zhang, X., Chen, F., Song, N., & Xie, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.689276 · Cited by 20
“Third, considering that neurodegenerative disorders tend to occur in older people, the age-related limitations of reprogramming must be taken into consideration, for example, astrocyte senescence is observed in patients of AD (Bhat et al., 2012), and PD (Chinta et al.”
BackgroundKawano, H., Oyabu, K., Yamamoto, H., Eto, K., Adaniya, Y., Kubota, K., Watanabe, T., Hirano‐Iwata, A., Nabekura, J., Katsurabayashi, S., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14247 · Cited by 20
“In the brain, astrocytes provide neurons with energy and secreted substrates, and play an active role in formation, maturation, and stabilization of functional synapses (Allen and Barres 2009; Bhat et al. 2012; Kawano et al. 2012).”
BackgroundThe role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer’s disease
Salminen, A. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02504-x · Cited by 17
Senescent Phenotype of Astrocytes Leads to Activation of BV2 Microglia and N2a Neuronal Cells Death
Zhang, Y. W., Yang, X., Liu, J., Pan, Y., Zhang, M., & Chen, L. (2022) · Molecules · doi:10.3390/molecules27185925 · Cited by 22
“The primary antibodies were: anti-P53 (Proteintech, Wuhan, China), anti-P21 (Proteintech, Wuhan, China), anti-P16 (Abcam, Cambridge, UK), anti-OPA-1 (Proteintech, Wuhan, China), anti-Mfn2 (Abcam Cambridge, UK), anti-DRP-1 (Proteintech, Wuhan, China), anti-β-actin (Proteintech, Wuhan, China).”
BackgroundInfluentialCellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Ojeda, D. S., López‐Costa, J. J., Sede, M. M., López, E. M., Berría, M. I., & Quarleri, J. F. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23294 · Cited by 19
“Interestingly, astrocytes undergo a functional decline with age in vivo that parallels functional declines in vitro, showing a telomere-aging process (Pertusa et al., 2007; Bhat et al., 2012).”
BackgroundSegmental Aging Underlies the Development of a Parkinson Phenotype in the AS/AGU Rat
Khojah, S. M., Payne, A., McGuinness, D., & Shiels, P. G. (2016) · Cells · doi:10.3390/cells5040038 · Cited by 16
“Interestingly, p16Ink4a and SA-β-Gal expression can be driven by β-amyloid in senescent astrocytes; however, the accumulation of SA-β-gal depends on pRB (retinoblastoma) functionality and is associated with the p21WAF1-mediated senescence pathway, independently of SA-β-gal status [38,39].”
BackgroundLana, D., Ugolini, F., & Giovannini, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249441 · Cited by 17
Palanivelu, L., Chen, Y., Chang, C., Liang, Y., Tseng, H.-Y., Li, S., Chang, C., & Lo, Y. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120899 · Cited by 16
“Since Axial Diffusivity primarily reflects axonal integrity rather than astrocytic changes, increases in astrocyte numbers or activity may not significantly influence Axial Diffusivity measurements (Bhat et al., 2012).”
Effect of Nrf2 loss on senescence and cognition of tau-based P301S mice
Riordan, R., Wang, R., Yu, Z., Ross, G., Valerio, J., Dimas-Muñoz, J., Heredia, V., Magnusson, K. R., Galván, V., & Pérez, V. (2023) · GeroScience · doi:10.1007/s11357-023-00760-2 · Cited by 15
“The SASP has recently emerged as a potential biomarker for early detection of AD, though cellular senescence in the brain remains largely unexplored [16].”
BackgroundNear-infrared II theranostic agents for the diagnosis and treatment of Alzheimer’s disease
Zhou, C., Zeng, F., Yang, H., Liang, Z., Xu, G., Li, X., Liu, X., & Yang, J. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06690-1 · Cited by 14
“…in which AβO is capable of producing neurotoxic effects through ROS production and Ca 2+ imbalance and also interacts with transition metal ions (e.g., Cu 2+ , Fe 3+ ) to mediate the production of H 2 O 2 and superoxide, inducing senescence in neuronal precursor cells [51] and astrocytes [52].”
Kumar, M., Swanson, N., Ray, S., Buch, S. J., Saraswathi, V., & Sil, S. (2024) · Cells · doi:10.3390/cells13141173 · Cited by 15
“These results are in alignment with previous research that highlights the crucial role of astrocytes in the progression of AD [31,71–73].”
ResultEffects of lifespan-extending interventions on cognitive healthspan
Čulig, L., Sahbaz, B. D., & Bohr, V. A. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.36 · Cited by 14
m6A methylation in cellular senescence of age-associated diseases
Gao, P., Yao, F., Pang, J., Yin, K., & Zhu, X. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023107 · Cited by 19
“When astrocytes age, they contribute to the development of AD through increased SASP, Aβ accumulation, tau protein phosphorylation, synaptic dysfunction, neuronal loss, and deposition of neurogenic fibrillary tangles [178,179].”
BackgroundZong, J., Yang, Y. X., Wang, H., Zhang, H., Yang, X., & Yang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1325908 · Cited by 20
Ran, Q., Song, D., Wang, Q., Wang, D., Chen, X., Zhang, A., & Ma, L. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04255-9 · Cited by 14
“Sublethal stresses such as oxidative stress or hypoxia induced by exogenous factors can lead to excessive cellular senescence via the excessive secretion of proinflammatory and profibrotic factors, thereby triggering degenerative processes or diseases [14–16].”
Taipa, R., Sousa, A., Melo-Pires, M., & Sousa, N. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160121 · Cited by 15
“Other lines of research have linked senescent astrocytes to the increase risk of sporadic AD [102].”
The Astrogenic Balance in the Aging Brain
Andromidas, F., Atashpanjeh, S., Myers, A. J., MacKinnon, B., Shaffer, M. M., & Koob, A. O. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210420095118 · Cited by 13
“Conversely, astrocyte senescence and atrophy have been observed early in dementia [31, 32].”
BackgroundAging-Related Tau Astrogliopathy in Aging and Neurodegeneration
McCann, H., Durand, B., & Shepherd, C. E. (2021) · Brain Sciences · doi:10.3390/brainsci11070927 · Cited by 19
Sumiyoshi, E., Hashimoto, M., Hossain, S., Matsuzaki, K., Islam, R., Tanabe, Y., Maruyama, K., Kajima, K., Arai, H., Ohizumi, Y., et al. (2021) · Food & Function · doi:10.1039/d0fo03272g · Cited by 16
Targeting Cellular Senescence: Pathophysiology in Multisystem Age-Related Diseases
Liu, J., Yu, H., & Xu, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13071727 · Cited by 15
“…age-matched controls, not only show significantly increased expression of the key senescence molecule CDKi p16INK4A but also markedly elevated expression of matrix metalloproteinase MMP1, further confirming the close association between astrocyte senescence and AD pathological development [126].”
Doxorubicin Induces a Senescent Phenotype in Murine and Human Astrocytes
Marques, M., Hayashide, L. D. S., Amorim, P., Fernandes, B. M., Araújo, A. P. B., Messor, D. F., Leocadio, V. E., Pessoa, B., Corrêa, J. B. L. P., Villablanca, C., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70177 · Cited by 16
“Additionally, astrocyte senescence models have shown that human astrocytes exhibit senescence features that are not fully replicated in murine models, including changes in gene expression linked to aging and inflammatory responses (Bhat et al. 2012).”
Dysfunction of the neurovascular unit in brain aging
Liu, S., Xu, Y., Chen, F., & Cai, Z. (2023) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220105 · Cited by 15
Mitochondria in cell senescence: A Friend or Foe?
Chen, Q., Young, L. H., & Barsotti, R. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.019 · Cited by 15
Senescence marker p16INK4a expression in patients with multiple sclerosis
Yang, J. H., Miner, A. E., Fair, A. E., Kinkel, R. P., & Graves, J. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105498 · Cited by 13
Cytokine profiling in senescent and reactive astrocytes: A systematic review
López‐Teros, M., Alarcón‐Aguilar, A., Alejandra, C.-A., Königsberg, M., & Luna‐López, A. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.02.012 · Cited by 15
Mott, N. N., Pinceti, E., Rao, Y. S., Przybycien–Szymanska, M. M., Prins, S. A., Shults, C. L., Yang, X., Glucksman, M., Roberts, J. L., & Pak, T. R. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.031559 · Cited by 16
Overexpression of Swedish mutant APP in aged astrocytes attenuates excitatory synaptic transmission
Katsurabayashi, S., Kawano, H., Ii, M., Nakano, S., Tatsumi, C., Kubota, K., Takasaki, K., 三島, 健., Fujiwara, M., & Iwasaki, K. (2016) · Physiological Reports · doi:10.14814/phy2.12665 · Cited by 12
“The expression of IL-6 mRNA increases significantly in aged astrocytes (Bhat et al. 2012), and therefore, we also measured and compared the IL-6 mRNA expression between 5- and 9-week-old cultures as an alternative assay for the determination of astrocyte aging.”
BackgroundDetecting Senescence: Methods and Approaches
Crowe, E. P., Nacarelli, T., Bitto, A., Lerner, C. A., Sell, C., & Torres, C. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_23 · Cited by 14
Self-citationBreast cancer type 1 and neurodegeneration: consequences of deficient DNA repair
Leung, E., & Hazrati, L. (2021) · Brain Communications · doi:10.1093/braincomms/fcab117 · Cited by 16
Launay, A., Carvalho, K., Génin, A., Gauvrit, T., Nobili, P., Gómez‐Murcia, V., Augustin, E., Burgard, A., Gambi, J., Fourmy, D., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03115-9 · Cited by 16
“4I, J; AAV-GFP: 8.78 ± 1.6 bursts/min vs. AAV-A2A: 15.56 ± 2.38 bursts/min; AAV-GFP: 8.78 + /-1.6 bursts/min; P = 0.036, Mann-Whitney test).”
InfluentialConnections Between Cellular Senescence and Alzheimer’s Disease—A Narrative Review
Kuźniar, J., Kozubek, P., Czaja, M., Sitka, H., Kochman, U., & Leszek, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178638 · Cited by 14
“SASP factors secreted by senescent astrocytes prone to induce inflammation include, for example, IL-6, IFN γ , TGF β , and CXCL10 [45,46].”
Senescent Astrocytes: A New Player in Brain Aging and Cognitive Decline
Pessoa, B., Hayashide, L. D. S., Dias, G. R., Pontes, B., Pinto, R. S., & Diniz, L. P. (2026) · Brain Sciences · doi:10.3390/brainsci16010076 · Cited by 14
Guerrero-González, C., Cueto‐Ureña, C., Cantón-Habas, V., Ramírez-Expósito, M. J., & Martínez-Martos, J. M. (2024) · Physiologia · doi:10.3390/physiologia4010007 · Cited by 20
“This is due to their ability to secrete and respond to large amounts of proinflammatory factors, such as chemokines and immunoregulatory cytokines, to different stimuli [17,96–100].”
Levis, H., Lewis, C., Fainor, M., Lawal, A., Stockham, E., Weston, J. D., Farhang, N., Gullbrand, S. E., & Bowles, R. D. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.11.007 · Cited by 15
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Maupin, E. A., & Adams, K. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16301 · Cited by 12
The Effects of IL-1β on Astrocytes are Conveyed by Extracellular Vesicles and Influenced by Age
Willis, C. M., Sutter, P. A., Rouillard, M. E., & Crocker, S. J. (2020) · Neurochemical Research · doi:10.1007/s11064-019-02937-8 · Cited by 13
Applications of nanodiamonds in the diagnosis and treatment of neurological diseases
Tang, G. F., Zhang, M. R., Liu, Q., Tian, X., & R., R. (2022) · Journal of Nanoparticle Research · doi:10.1007/s11051-022-05434-2 · Cited by 13
Activation of p38-mitogen-activated protein kinase contributes to ischemia reperfusion in rat brain.
Song, Y., Zou, H., Zhao, Y.-J., Yu, L.-Q., Tan, Z., & Kong, R. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15038492 · Cited by 14
“Thus, p38mapk may play a role in the etiology of AD and PD (Bhat et al., 2012; Wang et al., 2014b).”
BackgroundGammie, S. C., Messing, A., Hill, M. A., Kelm‐Nelson, C. A., & Hagemann, T. L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0291995 · Cited by 11
“Astrocytes in AD also display features of cellular senescence [60].”
BackgroundGenetic and Epigenetic Interactions Involved in Senescence of Stem Cells
Iordache, F., Ionescu, A., & Alexandru, D. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179708 · Cited by 14
Dziewa, M., Złotek, M., Herbet, M., & Piątkowska‐Chmiel, I. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01514-0 · Cited by 13
Alarcón‐Aguilar, A., González‐Puertos, V. Y., Luna‐López, A., López-Macay, Á., Morán, J., Santamaría, A., & Königsberg, M. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2841 · Cited by 13
“34 such as Alzheimer’s disease (Bhat et al., 2012) and Rett syndrome (Molofsky et al.”
BackgroundWillis, C. M., & Crocker, S. J. (2016) · InTech eBooks · doi:10.5772/62706 · Cited by 13
“This concept may contribute to how we might explain the role of astrocytes in dementia where dysregulation of synaptic connectivity and impaired cognitive function may relate to astrocyte senescence in Alzheim‐ er’s disease [153].”
BackgroundRole of Senescence and Neuroprotective Effects of Telomerase in Neurodegenerative Diseases
Ding, X., Liu, X., Wang, F., Wang, F., & Geng, X. (2019) · Rejuvenation Research · doi:10.1089/rej.2018.2115 · Cited by 12
“6,71,72 Other proliferative cell types in the brain undergo senescence, including oligodendrocytes, endothelial cells, and NSCs.”
The Hippo signaling pathway as a therapeutic target in Alzheimer’s disease
Chen, D., Wigglesworth-Littlewood, S., & Gunn, F. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00891-4 · Cited by 15
de Muniain, L. S., Escalada, P., Ramírez, M. J., & Solas, M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70252 · Cited by 16
“In fact, both Aβ and tau pathologies have been demonstrated to be potent inducers of cellular senescence (Liu 2022; Baker and Petersen 2018), and senescent cells have been detected in AD brains and mouse models (Baker and Petersen 2018; Bhat et al. 2012; Musi et al. 2018).”
Suk, K. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115737 · Cited by 13
The intersection between toxicology and aging research: A toxic aging coin perspective
Wise, J. P. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.1014675 · Cited by 14
“astrocytes can induce neuronal apoptosis or synaptic dysfunction (Pertusa et al., 2007; Bhat et al., 2012; Miranda et al., 2012).”
BackgroundThe putative contribution of cellular senescence to driving tauopathies
Karabag, D., Heneka, M. T., & Ising, C. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.006 · Cited by 11
Metadata
- Authors
- Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C.
- Affiliations
- Drexel University (US)
- University of Pennsylvania (US)
- Corresponding author
- Torres, Claudio
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-12
- Volume
- 7
- Issue
- 9
- Pages
- e45069
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3440417
- OpenAlex
- W2026433865
- Cited by
- 586
- References
- 64
- Citations by year
- 2026: 44 · 2025: 56 · 2024: 68 · 2023: 54 · 2022: 52 · 2021: 59 · 2020: 53 · 2019: 47 · 2018: 37 · 2017: 27 · 2016: 31 · 2015: 17 · 2014: 30 · 2013: 7 · 2012: 3
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Drexel University
- National Institutes of Health
- University of California, San Diego
- College of Medicine, Drexel University
- National Institute on Aging (AG022443-S1, AG022443, R01AG022443)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- astrocyte senescence, Alzheimer's disease, aging, p16INK4a, MMP-1, amyloid-beta 42, oxidative stress, senescence-associated β-galactosidase, interleukin-6, p38 MAPK, neuroinflammation, frontal cortex, sporadic Alzheimer's disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Astrocytes, Brain, Cells, Cultured, Cricetulus, Female, Cricetinae, Humans, Male, Microscopy, Fluorescence, Middle Aged, Peptide Fragments, Immunoblotting, Biomarkers, Interleukin-6, Amyloid beta-Peptides, CHO Cells, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Matrix Metalloproteinase 1, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.